You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Ukraine

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Consumer Health Resilient to Crisis

In 2011, consumer health registered double-digit growth in both volume and current value terms, and growth accelerated in a number of categories after the slowdown caused by the economic crisis. Self-medication is strong in Ukraine and during the crisis consumers self-medicated more than usual to avoid visiting doctors, which in turn boosted OTC volume growth. Prices of medicines increased, not always as a result of inflation, which also contributed to the strong growth at the end of the review period.

Rx Medicines Sold Without Prescriptions Press OTC Offers Still

Even though Rx and OTC medicines and how they can be distributed are legally defined in Ukraine, in reality buying Rx medicines without a prescription is common practice. Ukrainians unhappy with the local healthcare system, apart from self-medication, frequently rely on pharmacists’ advice for medicines and antibiotics. As a result Rx medicines can erode the potential of OTC products. The latter can use TV advertising to educate Ukrainians about products for minor problems. Preventative medication, increasingly common, was another driving force of consumer health at the end of the review period.

Global Crisis Added to Local Manufacturers’ Competitiveness in Ukraine

At the end of the review period local manufacturers of consumer health products were in a beneficial position in Ukraine. Considering the population of the country cannot boast of high income levels, the local currency’s strong devaluation at the end of 2008 hit consumers willing to purchase imported medicines. These became unaffordable and many consumers were forced to turn more frequently to local generics. A number of domestic operators strengthened their positions in consumer health even though they were more competitive in volume terms. Multinationals remained strong in the country, with leading positions in a number of consumer health categories.

Chemists/Pharmacies Still the Largest Distribution Channel

Chemists/pharmacies is the most important distribution channel for consumer health products in Ukraine due to local legislation on medicines distribution. Direct selling cannibalised the traditional channel’s sales even though it is limited to vitamins and dietary supplements as medicines are only available through chemists/pharmacies, parapharmacies/drugstores and online “outlets” of the latter. Amway Ukraine fuelled the dynamic growth of direct selling at the end of the review period. This was due partly to consumers seeking high quality and natural vitamins and dietary supplements, while the company focuses on the premium segment of the market. Ukrainians’ willingness to seek extra income during the economic crisis by working for a multi-level-marketing company was another factor behind the trend.

Consumer Health Performance in Future Depends on Government’s Initiatives

Over the forecast period consumer health is expected to perform under the impact of multiple factors. The long-lasting economic crisis is expected to limit the category’s short-term volume and value sales prospects although companies operating in the economy and standard segments are likely to fare better. The government is also likely to alter the category in future, especially after its efforts to ban the advertising of OTC medicines and internet sales come into force. Urging Ukrainians to visit doctors more frequently through medical insurance and family practitioners may divert consumers away from OTC products and towards Rx medicines.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Ukraine with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Ukraine, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Ukraine for free:

The Consumer Health in Ukraine market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Ukraine?
  • What are the major brands in Ukraine?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Ukraine - Industry Overview

EXECUTIVE SUMMARY

Consumer Health Resilient to Crisis

Rx Medicines Sold Without Prescriptions Press OTC Offers Still

Global Crisis Added to Local Manufacturers’ Competitiveness in Ukraine

Chemists/Pharmacies Still the Largest Distribution Channel

Consumer Health Performance in Future Depends on Government’s Initiatives

KEY TRENDS AND DEVELOPMENTS

Economic Hazards Restrict Consumer Health’s Potential

Preventative Medication Revives and Boosts VDS Sales

Widespread Self-Medication Contributes to OTC Sales

Fake Medicines Still a Headache for Ukrainian Healthcare

Local Manufacturers Gain Competitiveness

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC -Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Ukraine - Company Profiles

Borschahivsky KhFZ NVTs ZAT in Consumer Health (Ukraine)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Borschahivsky KhFZ NVTs ZAT: Production Statistics 4th Quarter 2011

COMPETITIVE POSITIONING

  • Summary 6 Borschahivsky KhFZ NVTs ZAT: Competitive Position 2011

Darnitsa FF ZAT in Consumer Health (Ukraine)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Darnitsa FF ZAT: Competitive Position 2011

Farmak VAT in Consumer Health (Ukraine)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 12 Farmak VAT: Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 13 Farmak VAT: Competitive Position 2011

Vitaminy VAT in Consumer Health (Ukraine)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 16 Vitaminy VAT: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 17 Vitaminy VAT: Competitive Position 2011

Zdorovya FK TOV in Consumer Health (Ukraine)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 19 Zdorovya FK TOV: Production Statistics 2009

COMPETITIVE POSITIONING

  • Summary 20 Zdorovya FK TOV: Competitive Position 2011

Adult Mouth Care in Ukraine - Category Analysis

HEADLINES

TRENDS

  • During the recession adult mouth care products were not considered essential by consumers, especially in rural areas where usage of traditional herbal medication remains common. For minor mouth problems people tend initially to self-medicate with, for example, honey and by rinsing with soda, chamomile, sage and other herbal brews. For more serious problems, consumers seek pharmacists’ advice, consult doctors or rely on their own knowledge gained through promotional campaigns. In 2011, retail value sales increased by 11% in current terms, lower than the review period CAGR of 18%. Retail value sales reached UAH82 million at the end of the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • At the end of the review period adult mouth care was shaped by the activities of a number of local and multinational companies. The latter were stronger in value terms due to higher unit prices of their products while local companies boosted their competitiveness through more affordable pricing. Respectively, in 2011 the top three positions belonged to multinationals – Norgine (53% of retail value sales), Bosnalijek Pharmaceuticals (9%) and Sagmel (7%).

PROSPECTS

  • Retail value sales of adult mouth care are expected to increase by 16% in constant terms over the forecast period to UAH95 million. The expected recovery of the country’s economy from crisis will allow Ukrainians to increase their expenditure on mouth care products, particularly in the long term. Home-made solutions for treating minor problems will lose their appeal as convenience and speed of treatment become priorities due to busier lifestyles.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In 2011, manufacturers of analgesics, international ones in particular, used TV advertising to boost consumer awareness of pain relief products. Higher consumer demand for original products, mainly international brands, caused by less economising after the peak of the financial crisis contributed to growth of 19% in current value terms in 2011 compared to the 14% CAGR of the review period. Unit price increases also contributed to value growth. Since inflation continued growing in Ukraine, rising manufacturing and logistics costs pushed up analgesics prices.

SWITCHES

COMPETITIVE LANDSCAPE

  • At the end of the review period analgesics was fragmented, with domestic and foreign manufacturers competing for share. The number one position belonged to a multinational player GlaxoSmithKline, which accounted for 21% of retail value sales in 2011. The company’s flagship brands were leaders in their respective categories – Panadol Baby accounted for 72% of paediatric acetaminophen, up two percentage points on the previous year while Solpadeine had a 38% retail value share in combination products – analgesics. With strong consumer awareness of the brands, supported by advertising at the end of the review period, GlaxoSmithKline posted the biggest gain in sales in 2011 – its share increased by one percentage point.

PROSPECTS

  • Analgesics is mature in Ukraine has growth potential due to the ageing population (the population aged over 60 is expected to grow from 7 million in 2011 to 7.3 million in 2016, according to Euromonitor International) as well as growing consumer interest in branded products. The latter factor will be dependent on the speed of economic recovery in the country, and provided the optimistic scenario is in place, the share of generics will fall. Analgesics is expected to register growth of 34% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Ukraine - Category Analysis

HEADLINES

TRENDS

  • Consumers began to return to calming and sleeping products in 2011. The financial crisis contributed to increased usage of home-made traditional/herbal treatments (eg, valerian root) as a way to economise. However, as the economy showed signs of stability consumers reverted to convenient and easy to use calming and sleeping products. In 2011, retail value sales increased by 14% in current terms, close to the review period CAGR of 15%, and reached UAH192 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Laboratoires UPSA was the leading operator in calming and sleeping with a 16% share of retail value sales thanks to its flagship brand Donormyl. The company suffered during the financial crisis in 2010 when buyers of premium products shifted to cheaper domestic variants of calming and sleeping products. In 2011, consumers returned to the regularly advertised Donormyl, as a more stable economy encouraged higher spending on medicines. As a result the company registered the most dynamic performance and increased its retail value share by two percentage points.

PROSPECTS

  • Increasingly hectic lifestyles and a growing preference for original medicines in Ukraine are expected to contribute to retail value growth of 46% in constant terms in calming and sleeping over the forecast period, to UAH281 million.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In Ukraine, self-medication for coughs, colds and allergies is widespread, with consumer knowledge about such medicines boosted by regular TV advertising. While visiting doctors for such ailments is generally avoided due largely to the poor healthcare system and consumers’ belief in their ability to treat “minor” problems, many people, especially in urban areas, tend not to take time off work for colds but instead take products that suppress the symptoms, such as Fervex. In 2011, demand for OTC medicines to treat coughs, colds and allergies was healthy and combined with price increases contributed to the category’s retail value growth of 11% in current terms to UAH1.9 billion. However, due to the prevailing recession this was below the review period CAGR of 16%.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 cough, cold and allergy (hay fever) remedies had its performance shaped by dozens of companies the largest of which included Farmak, GlaxoSmithKline and Laboratoires UPSA. Farmak is a giant domestic manufacturer of a wide assortment of Rx and OTC medicines, with a range of cough, cold and allergy products, the most popular of which include Amizon, Farmazolinum and Rinazolin. In 2011, the company was the leading player with 12% of retail value sales – up one percentage point on the previous year due to the successful performance of its flagship brand Amizon (supported by TV advertisements which highlight its claim of helping to prevent colds by boosting immunity).

PROSPECTS

  • In future, the maturity of cough, cold and allergy (hay fever) remedies will limit its growth potential. Retail value sales are expected to increase by 10% in constant terms over the forecast period. Home-made herbal/traditional cough and cold, and to a lesser extent allergy, treatments are expected to prevail in future due to the nature of such illnesses (comparatively easy to cure). They will present a threat to sales of cough, cold and allergy (hay fever) remedies over the forecast period.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In 2011, digestive remedies was one of the most modest performers with value sales up by 11% current value growth notwithstanding further price increases on medicines. Digestive remedies are not viewed as essential products for minor ailments as Ukrainians know many herbal/traditional remedies (such as herbs, dried fruits, alcohol with salt etc). Due to the strong tradition of self-medication for digestive problems, slight growth in consumer confidence was not enough to boost consumer demand for OTC digestive medicines. As a result, the 2011 value sales dynamics was even weaker compared to the historic CAGR of 13% of current value sales.

SWITCHES

COMPETITIVE LANDSCAPE

  • Brand advertising is important in digestive remedies and the leading products belonged to companies which invested heavily in this type of promotional support. In 2011, Chinoin Pharmaceutical & Chemical Works led the category with 16% of retail value sales through its flagship No-spa brand (popular as a painkiller and for indigestion).

PROSPECTS

  • Digestive remedies is expected to increase by 5% in constant value terms over the forecast period. The eventual economic recovery from the financial crisis will lead to growth in consumer expenditure on medicines. A higher incidence of digestive problems is expected as a result of more stressful and busier consumer lifestyles complicated by use of junk and fast food.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Ukraine - Category Analysis

HEADLINES

TRENDS

  • Self-medication for ailments including minor ear problems is common in Ukraine. However, with lifestyles becoming increasingly hectic, traditional methods such as using walnut oil are in decline. Ukrainians are seeking more convenient and efficient products, particularly in OTC ear care. Rx medicines for ear care exist but are mainly purchased after consultations with otolaryngologists, which limits their impact on OTC ear care.

SWITCHES

COMPETITIVE LANDSCAPE

  • Leading player Aventis accounted for 36% of retail value sales in 2011 due to the success of its flagship Sofradex brand. The pioneering foreign company, which has a national distribution network, increased its share by four percentage points on the previous year. Aventis benefited from growing consumer interest in standard brands, such as its Sofradex, rather than cheap generics.

PROSPECTS

  • Ear care will approach saturation point over the forecast period and growth is expected to slow down, to 4% in constant value terms.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In 2011, the domestic economy was characterised by eventual stabilisation which spurred consumers to increase expenditure, including expenditure on OTC consumer health products. Computer ownership increased while environmental pollution led to a higher incidence of eye allergies. Unit prices of eye care increased and consumers started opting for more original medicines. As a result of these developments, value sales grew by 5% in current value terms to UAH52 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • At the end of the review period a number of domestic and foreign manufacturers competed in eye care. The former primarily offered cheaper generics while multinationals offered branded products usually supported by advertising campaigns. Pharmacists play a key role in the choice of eye care products as a number of Ukrainians seek their advice rather than consult a doctor.

PROSPECTS

  • In future, eye care is expected to pick up if the economy recovers. As spending power increases consumers are expected to favour eye care products over home-made herbal remedies, with an eventual shift to branded products rather than generics. Also, rising computer ownership is set to contribute to further expansion of the consumer base for eye care products. Eye care is expected to register growth of 18% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2006-2011
  • Table 53 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 54 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 55 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 56 Eye Care Company Shares by Value 2007-2011
  • Table 57 Eye Care Brand Shares by Value 2008-2011
  • Table 58 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In 2011, retail value sales in herbal/traditional products increased by 10% in current terms to UAH742 million. Even though sales were partly boosted by rising prices of consumer health products, including herbal/traditional products, Ukrainians still favour such medicines. Herbal/traditional products appeal due to the naturalness of their ingredients, and thus less harmful and milder effects, and are particularly popular with people following health and wellness lifestyles. However, the category approached saturation and current value growth in 2011 was lower than the review period CAGR of 13%.

COMPETITIVE LANDSCAPE

  • In 2011, herbal/traditional products remained highly fragmented, and others accounted for half of retail value sales. Herbal-based ingredients are used in a number of types of medicine, which explains the fragmentation. Aim was the leading player – its herbal/traditional medicinal teas were particularly popular (and comparatively expensive). Together with efficient distribution, the company’s product range allowed it to generate 6% of retail value sales in 2011.

PROSPECTS

  • The appeal of herbal/traditional products is expected to grow as the growing fashion for preventative medication and healthy eating/drinking will make Ukrainians increasingly concerned about the possible side effects of medicines. Herbal/traditional products will be resorted to more frequently as their impact on health is viewed as more natural and milder. As the economy continues to recover and unless there is another upset Ukrainians are expected to switch from home-made herbal teas to packaged herbal/traditional products, which are quicker and more convenient to consume. Herbal/traditional products is expected to increase by 11% in constant value terms over the forecast period.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 62 Herbal/Traditional Products Company Shares 2007-2011
  • Table 63 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In 2011, medicated skin care registered current value growth of 12%, below the review period CAGR of 14%, to UAH453 million. Even though Ukrainians became less economical in 2011, another year of relative economic stabilisation, sales were driven largely by rising prices. Higher manufacturing and logistics costs were passed on to consumers. Consumers regularly self-medicate and tend to buy advertised products (usually more expensive than generics), which also contributes to value over volume sales dominance in medicated skin care.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 medicated skin care was highly fragmented, with more than a half of companies having shares below 1% of retail value sales. STADA Arzneimittel was the leader with 12% of retail value sales in 2011. The company is present in cold sore treatments (Aciclovir), haemorrhoid treatments (Proctosan), and topical allergy remedies/antihistamines (Psilo-Balsam). STADA’s products benefited from nationwide distribution and its long-established brands enjoy consumer loyalty and promotional support.

PROSPECTS

  • Medicated skin care is expected to register a CAGR of 2% in constant value terms over the forecast period to reach UAH510 million. Rising incomes and interest in original products supported by advertising campaigns are expected to boost sales.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 68 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 69 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 70 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 71 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Ukraine - Category Analysis

HEADLINES

TRENDS

  • At the end of the review period Ukrainian smokers had their habit further pressurised by the government’s initiatives to reduce smoking through tax increases and restrictions on public smoking. Smoking in banned places was not a major issue due to lack of enforcement but higher prices encouraged a growing number of price-sensitive Ukrainians to quit smoking. While in 2006 there were 14 million smokers in Ukraine, by 2011 the number had fallen to 10 million.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, Pharmacia remained the only player in NRT smoking cessation aids in Ukraine. It offers its Nicorette assortment of gum and patches (March 2010 launch). The company shapes the category’s performance on its own despite competition from traditional/herbal smoking cessation aids. Despite a limited range traditional/herbal smoking cessation aids appeal due to lower prices per unit. For example, 100 units of Tabex cost UAH135 in 2011 while Confer NRT patches cost UAH140 for seven units.

PROSPECTS

  • Over the forecast period anti-tobacco campaigns are expected to become more active in Ukraine, including negative publicity in mass media and further increases in prices through taxes hikes. Restrictions on tobacco consumption in public places and advertising bans will remain in place and continue to undermine the appeal of cigarettes to young Ukrainians. In future, the number of smokers is expected to keep falling, down from 10 million in 2011 to 9 million in 2016. NRT smoking cessation aids will benefit from the trend with value sales expected to rise by 11% in constant value terms over the forecast period.

CATEGORY INDICATORS

  • Table 72 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 73 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 74 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 75 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 76 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 77 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 78 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 79 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In 2011, sports nutrition was largely underdeveloped in Ukraine with value sales of just UAH5 million. Ukrainians cannot be characterised as keen on sports, which explains low demand for such products. On the other hand, a number of sports clubs and individuals distribute such products illegally. Thus the category, which emerged in 2009, has yet to realise its potential. In 2011 retail value sales increased by 18% in current terms as economic stabilisation contributed to growth in consumer expenditure on such products. At the end of the review period sports nutrition products continued to benefit from novelty appeal.

COMPETITIVE LANDSCAPE

  • At the end of the review period the competitive landscape of sports nutrition was multi-faceted due to sporadic and disorganised imports of such products, including private imports.

PROSPECTS

  • Over the forecast period retail value sales in sports nutrition are expected to increase by 39% in constant terms as Ukrainians play sports more frequently. The unsaturated nature of the category and the products’ novelty will also contribute to growth.

CATEGORY DATA

  • Table 80 Sales of Sports Nutrition: Value 2007-2011
  • Table 81 Sales of Sports Nutrition: % Value Growth 2007-2011
  • Table 82 Sports Nutrition Company Shares 2007-2011
  • Table 83 Sports Nutrition Brand Shares 2008-2011
  • Table 84 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 85 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Ukraine - Category Analysis

HEADLINES

TRENDS

  • In 2011, as consumer confidence began to recover, vitamins and dietary supplements returned to positive growth with retail value sales up 8% in current terms to UAH1.4 billion. This was below the CAGR for the review period as a whole but a number of categories demonstrated strong volume growth, including Echinacea (11%), berry (13%) and sea products (10%). With a more stable economy, consumers increased expenditure on vitamins and dietary supplements for preventative purposes.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • In 2011, vitamins and dietary supplements was highly fragmented, with an extensive range of products falling into different pharmaceutical groups. Apart from two top players, Amway (its Nutrilite range accounted for 18% retail value sales) and Sagmel (Health Life with 9%), the remaining players held shares of less than 7%, the majority with only a negligible presence.

PROSPECTS

  • Over the forecast period vitamins and dietary supplements is expected to grow by 16% in constant value terms over the forecast period. The anticipated economic recovery and the respective strengthening of consumer spending power will allow Ukrainians to be less economical with purchases of such products. Stronger growth is expected towards the end of the forecast period, with demand for premium products set to remain constrained in the short term.

CATEGORY DATA

  • Summary 21 Dietary Supplements: Brand Ranking by Positioning 2011
  • Table 86 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 87 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 88 Dietary Supplements by Positioning 2006-2011
  • Table 89 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 90 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 91 Vitamins Brand Shares by Value 2008-2011
  • Table 92 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 93 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 94 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Ukraine - Category Analysis

HEADLINES

TRENDS

  • Despite strong growth and development over the review period some niches within weight management remained underrepresented in 2011. Its performance was shaped by slimming teas and weight loss supplements alone. The only product in OTC obesity, Xenical, switched to Rx status in 2010. Meal replacement slimming and other slimming products remained market negligible with only limited assortments on offer.

COMPETITIVE LANDSCAPE

  • While Amway and Herbalife were shaping weight management’s performance at the time of its emergence (2004-2006), the competitive landscape became more concentrated by the end of the review period. FitobioTekhnologii and Tiens Corp entered market in 2006. Also, Russian company Evalar penetrated the category aggressively from 2010 and appealed to post-crisis consumers with its competitively priced TurboSlim brand.

PROSPECTS

  • Over the forecast period weight management is expected to develop as obesity increases in the country in line with global trends of overeating and lack of exercise. Between 2011 and 2016 the sector is anticipated to register a CAGR of 7% in constant value terms and reach UAH110 million.

CATEGORY DATA

  • Table 95 Sales of Weight Management: Value 2006-2011
  • Table 96 Sales of Weight Management: % Value Growth 2006-2011
  • Table 97 Weight Management Company Shares 2007-2011
  • Table 98 Weight Management Brand Shares 2008-2011
  • Table 99 Forecast Sales of Weight Management: Value 2011-2016
  • Table 100 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Ukraine - Category Analysis

HEADLINES

TRENDS

  • During the financial crisis wound care could not boast of new technological delivery formats or other progressive changes and remained one of the most mature categories in OTC consumer health in Ukraine. Consumer spending increased, which benefited wound care, as the economy recovered slowly from the financial crisis. Retail value sales increased by 11% in current terms to UAH141 million in 2011 – however, this represented slower growth than the CAGR of 16% for the review period as the category moved closer to its saturation point.

COMPETITIVE LANDSCAPE

  • In 2011 wound care in Ukraine was led by foreign operators. Russian companies Veropharm, Voronezhsky and French Laboratoires Urgo held the top three positions. Veropharm held a 25% retail value share in 2011 thanks to its strong position in sticking plasters/adhesive bandages. The company operates in the low-to-middle end of the market and during the crisis its products offered value for money. Good quality products at reasonable prices (combined with national distribution coverage) were of appeal at the end of the review period, which allowed the company to post the biggest growth in share in 2011.

PROSPECTS

  • Over the forecast period wound care is expected to post a marginal CAGR of 1% in constant value terms. Ukrainians are likely to give increasing preference to more expensive products, plasters in particular, provided the economy continues to recover. In volume terms, the category will be restricted, however, eventually approaching its saturation point.

CATEGORY DATA

  • Table 101 Sales of Wound Care by Category: Value 2006-2011
  • Table 102 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 103 Wound Care Company Shares by Value 2007-2011
  • Table 104 Wound Care Brand Shares by Value 2008-2011
  • Table 105 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 106 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Berry
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Sea Products
            • Yeast
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Paediatric Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Paediatric Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Paediatric Consumer Health
      • Paediatric Analgesics
        • Paediatric Acetaminophen
        • Paediatric Aspirin
        • Paediatric Combination Products - Analgesics
        • Paediatric Diclofenac
        • Paediatric Dipyrone
        • Paediatric Ibuprofen
        • Paediatric Ketoprofen
        • Paediatric Naproxen
      • Paediatric Cough, Cold and Allergy Remedies
        • Paediatric Allergy Remedies
        • Paediatric Cough/Cold Remedies
      • Paediatric Digestive Remedies
        • Paediatric Diarrhoeal Remedies
        • Paediatric Indigestion and Heartburn Remedies
        • Paediatric Laxatives
        • Paediatric Motion Sickness Remedies
      • Paediatric Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Paediatric Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!